Titertek-Berthold / Berthold Detection Systems GmbH and the life science business of Berthold Technologies GmbH & Co. KG (“Bioanalytic”) will join forces, effective January 1, 2017. We will deliver even greater benefits to our combined customers and business partners through a broadened portfolio of integrated system solutions for the life science laboratory: These range from small standalone readers, such as microvolume spectrometers and luminometers to various dedicated and multimode readers, microplate washers, microplate workstations, RIA and ELISA automation products and high-end imaging systems.
The Berthold Technologies group operates from the Bad Wildbad/Germany headquarter, and has affiliate companies and strong partners globally. All activities of Titertek-Berthold will be moved to the Berthold Technologies headquarter. The newly combined life science business unit will be led by Dr. Anselm Berthold, owner and president of Titertek-Berthold and shareholder of Berthold Technologies GmbH.